Quest Diagnostics Future Growth
Future criteria checks 1/6
Quest Diagnostics is forecast to grow earnings and revenue by 11.7% and 5% per annum respectively. EPS is expected to grow by 11.1% per annum. Return on equity is forecast to be 15.5% in 3 years.
Key information
11.7%
Earnings growth rate
11.1%
EPS growth rate
| Healthcare earnings growth | 20.7% |
| Revenue growth rate | 5.0% |
| Future return on equity | 15.5% |
| Analyst coverage | Good |
| Last updated | 23 Dec 2024 |
Recent future growth updates
Earnings Update: Quest Diagnostics Incorporated (NYSE:DGX) Just Reported Its Third-Quarter Results And Analysts Are Updating Their Forecasts
Oct 25
Results: Quest Diagnostics Incorporated Beat Earnings Expectations And Analysts Now Have New Forecasts
Apr 26Recent updates
Is Quest Diagnostics (NYSE:DGX) A Risky Investment?
Dec 18Is Now The Time To Look At Buying Quest Diagnostics Incorporated (NYSE:DGX)?
Nov 30Investors Met With Slowing Returns on Capital At Quest Diagnostics (NYSE:DGX)
Nov 12Earnings Update: Quest Diagnostics Incorporated (NYSE:DGX) Just Reported Its Third-Quarter Results And Analysts Are Updating Their Forecasts
Oct 25Quest Diagnostics: Organic Growth Leads To Q3 Earnings Beat
Oct 24Why Investors Shouldn't Be Surprised By Quest Diagnostics Incorporated's (NYSE:DGX) P/E
Oct 23Quest Diagnostics: The Better Half Of An Emerging Healthcare Duopoly
Oct 15These 4 Measures Indicate That Quest Diagnostics (NYSE:DGX) Is Using Debt Reasonably Well
Aug 30Should You Think About Buying Quest Diagnostics Incorporated (NYSE:DGX) Now?
Aug 12Quest Diagnostics: Beat Down After Beating Q2 Estimates
Jul 28The Price Is Right For Quest Diagnostics Incorporated (NYSE:DGX)
Jul 12Quest Diagnostics: On A Quest For Growth
Jul 12Quest Diagnostics (NYSE:DGX) Hasn't Managed To Accelerate Its Returns
May 14Quest Diagnostics: Let's Keep Waiting
May 08Results: Quest Diagnostics Incorporated Beat Earnings Expectations And Analysts Now Have New Forecasts
Apr 26We Think Quest Diagnostics (NYSE:DGX) Can Stay On Top Of Its Debt
Apr 23Unpleasant Surprises Could Be In Store For Quest Diagnostics Incorporated's (NYSE:DGX) Shares
Apr 02Quest Diagnostics (NYSE:DGX) Is Paying Out A Larger Dividend Than Last Year
Mar 15Quest Diagnostics (NYSE:DGX) Has Announced That It Will Be Increasing Its Dividend To $0.75
Feb 06Quest Diagnostics: Post-COVID Normalization Pretty Much Done
Feb 05Quest Diagnostics (NYSE:DGX) Seems To Use Debt Quite Sensibly
Jan 11Quest Diagnostics: Market Overreaction Creates Investment Opportunity
Dec 08Quest Diagnostics: Moving Past Covid
Oct 25Quest Diagnostics: Q2 Earnings Reveal Promising Growth Trends Despite Dwindling COVID Testing Revenues
Aug 15Quest Diagnostics: Healthier Diagnosis
May 30Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 11,050 | 1,092 | 1,308 | 1,700 | 14 |
| 12/31/2025 | 10,664 | 1,004 | 1,162 | 1,531 | 16 |
| 12/31/2024 | 9,833 | 910 | 931 | 1,286 | 14 |
| 9/30/2024 | 9,539 | 838 | 1,023 | 1,397 | N/A |
| 6/30/2024 | 9,346 | 836 | 875 | 1,248 | N/A |
| 3/31/2024 | 9,287 | 842 | 947 | 1,332 | N/A |
| 12/31/2023 | 9,252 | 850 | 864 | 1,272 | N/A |
| 9/30/2023 | 9,297 | 759 | 596 | 1,079 | N/A |
| 6/30/2023 | 9,488 | 790 | 878 | 1,374 | N/A |
| 3/31/2023 | 9,603 | 789 | 864 | 1,332 | N/A |
| 12/31/2022 | 9,883 | 942 | 1,314 | 1,718 | N/A |
| 9/30/2022 | 10,294 | 1,230 | 1,464 | 1,865 | N/A |
| 6/30/2022 | 10,582 | 1,479 | 1,552 | 1,924 | N/A |
| 3/31/2022 | 10,679 | 1,874 | 1,602 | 1,982 | N/A |
| 12/31/2021 | 10,788 | 1,988 | 1,830 | 2,233 | N/A |
| 9/30/2021 | 11,046 | 2,175 | 1,872 | 2,293 | N/A |
| 6/30/2021 | 11,058 | 2,238 | 2,171 | 2,594 | N/A |
| 3/31/2021 | 10,335 | 1,794 | 2,068 | 2,489 | N/A |
| 12/31/2020 | 9,437 | 1,425 | 1,587 | 2,005 | N/A |
| 9/30/2020 | 8,361 | 1,101 | 1,384 | 1,812 | N/A |
| 6/30/2020 | 7,531 | 749 | 816 | 1,249 | N/A |
| 3/31/2020 | 7,657 | 771 | 779 | 1,215 | N/A |
| 12/31/2019 | 7,726 | 835 | 843 | 1,243 | N/A |
| 9/30/2019 | 7,639 | 709 | 811 | 1,190 | N/A |
| 6/30/2019 | 7,572 | 707 | 929 | 1,293 | N/A |
| 3/31/2019 | 7,538 | 720 | 938 | 1,295 | N/A |
| 12/31/2018 | 7,531 | 733 | 817 | 1,200 | N/A |
| 9/30/2018 | 7,557 | 860 | 914 | 1,228 | N/A |
| 6/30/2018 | 7,524 | 808 | N/A | 1,188 | N/A |
| 3/31/2018 | 7,469 | 782 | N/A | 1,159 | N/A |
| 12/31/2017 | 7,402 | 769 | N/A | 1,175 | N/A |
| 9/30/2017 | 7,398 | 671 | N/A | 1,156 | N/A |
| 6/30/2017 | 7,427 | 701 | N/A | 1,095 | N/A |
| 3/31/2017 | 7,469 | 702 | N/A | 1,112 | N/A |
| 12/31/2016 | 7,214 | 642 | N/A | 1,116 | N/A |
| 9/30/2016 | 7,503 | 675 | N/A | 1,037 | N/A |
| 6/30/2016 | 7,498 | 825 | N/A | 948 | N/A |
| 3/31/2016 | 7,517 | 748 | N/A | 922 | N/A |
| 12/31/2015 | 7,493 | 706 | N/A | 821 | N/A |
| 9/30/2015 | 7,527 | 703 | N/A | 852 | N/A |
| 6/30/2015 | 7,551 | 491 | N/A | 911 | N/A |
| 3/31/2015 | 7,528 | 507 | N/A | 906 | N/A |
| 12/31/2014 | 7,435 | 549 | N/A | 944 | N/A |
| 9/30/2014 | 7,308 | 506 | N/A | 845 | N/A |
| 6/30/2014 | 7,192 | 780 | N/A | 761 | N/A |
| 3/31/2014 | 7,105 | 799 | N/A | 689 | N/A |
| 12/31/2013 | 7,146 | 811 | N/A | 652 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: DGX's forecast earnings growth (11.7% per year) is above the savings rate (2.6%).
Earnings vs Market: DGX's earnings (11.7% per year) are forecast to grow slower than the US market (15.3% per year).
High Growth Earnings: DGX's earnings are forecast to grow, but not significantly.
Revenue vs Market: DGX's revenue (5% per year) is forecast to grow slower than the US market (9.2% per year).
High Growth Revenue: DGX's revenue (5% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: DGX's Return on Equity is forecast to be low in 3 years time (15.5%).
Discover growth companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/30 22:37 |
| End of Day Share Price | 2024/12/30 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Quest Diagnostics Incorporated is covered by 46 analysts. 16 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Jasper Hellweg | Argus Research Company |
| Brian Kemp Dolliver | Avondale Partners |
| Eric Coldwell | Baird |